Cornerstone National Bank & Trust’s Edwards Lifesciences EW Stock Holding History

Cornerstone National Bank & Trust’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,000	Closed	-$256K	–	219
2025 Q4	$256K	Hold	3,000	–	–	0.1%	62
2025 Q3	$233K	Hold	3,000	–	–	0.1%	61
2025 Q2	$235K	Hold	3,000	–	–	0.1%	61
2025 Q1	$217K	Hold	3,000	–	–	0.1%	61
2024 Q4	$222K	Hold	3,000	–	–	0.1%	61
2024 Q3	$198K	Sell	3,000 -382	-11%	-$27.8K	0.09%	63
2024 Q2	$312K	Hold	3,382	–	–	0.15%	59
2024 Q1	$323K	Hold	3,382	–	–	0.16%	58
2023 Q4	$258K	Hold	3,382	–	–	0.14%	58
2023 Q3	$234K	Hold	3,382	–	–	0.14%	55
2023 Q2	$319K	Hold	3,382	–	–	0.18%	52
2023 Q1	$280K	Hold	3,382	–	–	0.15%	52
2022 Q4	$252K	Hold	3,382	–	–	0.14%	54
2022 Q3	$279K	Hold	3,382	–	–	0.15%	57
2022 Q2	$322K	Sell	3,382 -1,005	-23%	-$104K	0.16%	55
2022 Q1	$516K	Buy	4,387 +975	+29%	+$109K	0.23%	53
2021 Q4	$442K	Hold	3,412	–	–	0.19%	57
2021 Q3	$386K	Hold	3,412	–	–	0.17%	56
2021 Q2	$353K	Sell	3,412 -16	-0.5%	-$1.51K	0.15%	57
2021 Q1	$287K	Sell	3,428 -679	-17%	-$57.4K	0.13%	58
2020 Q4	$375K	Sell	4,107 -71	-2%	-$5.89K	0.2%	55
2020 Q3	$333K	Sell	4,178 -284,564	-99%	-$22.2M	0.21%	52
2020 Q2	$289K	Buy	288,742 +284,497	+6,702%	+$20.2M	0.21%	53
2020 Q1	$267K	Sell	4,245 -339	-7%	-$24.4K	0.24%	52
2019 Q4	$356K	Buy	+4,584	New	+$358K	0.32%	51

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Cornerstone National Bank & Trust's EW Position: Q1 2026 in Review

Cornerstone National Bank & Trust sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 3,000 shares — an estimated $256K sold.

Cornerstone National Bank & Trust first reported a position in EW in Q4 2019 and held it in 25 quarters. The position peaked at $516K in Q1 2022. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Cornerstone National Bank & Trust reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
Cornerstone National Bank & Trust sold 3,000 Edwards Lifesciences shares in Q1 2026, an estimated $256K.
Cornerstone National Bank & Trust first reported a position in Edwards Lifesciences in Q4 2019 and held it in 25 quarters.
Cornerstone National Bank & Trust's Edwards Lifesciences position peaked at $516K in Q1 2022.
1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Cornerstone National Bank & Trust's 13F filing for Q1 2026, filed 14 Apr 2026.